Real-time
Borsa Italiana
06:57:24 2024-06-03 am EDT
|
5-day change
|
1st Jan Change
|
98.94
EUR
|
0.00%
|
|
+0.14%
|
+6.13%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,315
|
9,289
|
9,163
|
6,962
|
4,969
|
5,272
|
-
|
-
|
Enterprise Value (EV)
1 |
6,142
|
8,984
|
10,149
|
7,868
|
5,745
|
5,996
|
5,803
|
5,607
|
P/E ratio
|
36.1
x
|
37.5
x
|
31
x
|
31.4
x
|
32.5
x
|
30
x
|
25.9
x
|
22.3
x
|
Yield
|
0.82%
|
0.59%
|
0.63%
|
0.84%
|
1.24%
|
0.92%
|
1.07%
|
1.15%
|
Capitalization / Revenue
|
8.94
x
|
10.5
x
|
7.4
x
|
5.11
x
|
4.33
x
|
4.44
x
|
4.13
x
|
3.83
x
|
EV / Revenue
|
8.7
x
|
10.2
x
|
8.2
x
|
5.78
x
|
5
x
|
5.05
x
|
4.55
x
|
4.07
x
|
EV / EBITDA
|
22.2
x
|
23.3
x
|
18.7
x
|
15.3
x
|
15.3
x
|
15.6
x
|
13.6
x
|
11.8
x
|
EV / FCF
|
34.1
x
|
38.8
x
|
33.7
x
|
24.9
x
|
29
x
|
28
x
|
24.1
x
|
20.4
x
|
FCF Yield
|
2.93%
|
2.58%
|
2.96%
|
4.02%
|
3.45%
|
3.57%
|
4.15%
|
4.89%
|
Price to Book
|
7.61
x
|
9.74
x
|
6.71
x
|
4.56
x
|
3.23
x
|
3.13
x
|
2.96
x
|
2.88
x
|
Nbr of stocks (in thousands)
|
54,723
|
54,608
|
54,719
|
53,388
|
53,289
|
53,285
|
-
|
-
|
Reference price
2 |
115.4
|
170.1
|
167.4
|
130.4
|
93.24
|
98.94
|
98.94
|
98.94
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/16/22
|
3/27/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
706.3
|
881.3
|
1,238
|
1,361
|
1,148
|
1,188
|
1,275
|
1,378
|
EBITDA
1 |
276.8
|
385.3
|
543.1
|
514.2
|
375
|
383.8
|
426.3
|
476.8
|
EBIT
1 |
217.9
|
324.2
|
465.1
|
417
|
283
|
272.9
|
310.4
|
355.3
|
Operating Margin
|
30.85%
|
36.79%
|
37.58%
|
30.64%
|
24.65%
|
22.97%
|
24.34%
|
25.78%
|
Earnings before Tax (EBT)
1 |
216.3
|
321.4
|
399.3
|
325.9
|
201
|
237.3
|
279.1
|
324.9
|
Net income
1 |
175.7
|
248.3
|
310.7
|
240.1
|
159
|
193.8
|
213.6
|
247.5
|
Net margin
|
24.88%
|
28.17%
|
25.1%
|
17.64%
|
13.85%
|
16.32%
|
16.75%
|
17.96%
|
EPS
2 |
3.200
|
4.534
|
5.400
|
4.150
|
2.870
|
3.301
|
3.822
|
4.441
|
Free Cash Flow
1 |
180.1
|
231.6
|
300.7
|
316
|
198.4
|
214.1
|
241
|
274.4
|
FCF margin
|
25.5%
|
26.28%
|
24.3%
|
23.22%
|
17.28%
|
18.02%
|
18.9%
|
19.91%
|
FCF Conversion (EBITDA)
|
65.07%
|
60.11%
|
55.37%
|
61.45%
|
52.91%
|
55.77%
|
56.53%
|
57.55%
|
FCF Conversion (Net income)
|
102.5%
|
93.27%
|
96.78%
|
131.61%
|
124.79%
|
110.46%
|
112.82%
|
110.9%
|
Dividend per Share
2 |
0.9500
|
1.000
|
1.050
|
1.100
|
1.158
|
0.9098
|
1.059
|
1.142
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/16/22
|
3/27/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
356
|
382.3
|
515.4
|
343.5
|
378.8
|
357.6
|
327.8
|
685.4
|
326.8
|
348.8
|
289.6
|
286.8
|
576.4
|
270
|
302
|
289
|
301.3
|
278.4
|
340.6
|
256.2
|
EBITDA
1 |
-
|
153.6
|
244.2
|
139.2
|
159.9
|
149.8
|
119.3
|
269.1
|
122.1
|
123
|
97.5
|
92.5
|
190
|
88
|
97
|
97
|
108.4
|
97.64
|
111.9
|
-
|
EBIT
1 |
-
|
123.6
|
201.9
|
112.2
|
151
|
126.2
|
95.17
|
221.4
|
97.3
|
98.3
|
74.8
|
69.6
|
144.4
|
-
|
74
|
74
|
64.37
|
62.64
|
77.78
|
65.94
|
Operating Margin
|
-
|
32.33%
|
39.17%
|
32.66%
|
39.86%
|
35.29%
|
29.03%
|
32.3%
|
29.77%
|
28.18%
|
25.83%
|
24.27%
|
25.05%
|
-
|
24.5%
|
25.61%
|
21.36%
|
22.5%
|
22.83%
|
25.74%
|
Earnings before Tax (EBT)
1 |
-
|
122.2
|
196.1
|
103.6
|
99.5
|
106.2
|
75.58
|
181.8
|
80.1
|
64
|
54.5
|
-
|
-
|
-
|
56
|
59
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
94.7
|
150
|
79.3
|
81.4
|
82.3
|
58.51
|
140.8
|
62.1
|
37.2
|
41.7
|
45.1
|
86.9
|
-
|
47
|
46
|
50.95
|
47.91
|
61.07
|
-
|
Net margin
|
-
|
24.77%
|
29.1%
|
23.09%
|
21.49%
|
23.01%
|
17.85%
|
20.54%
|
19%
|
10.67%
|
14.4%
|
15.73%
|
15.08%
|
-
|
15.56%
|
15.92%
|
16.91%
|
17.21%
|
17.93%
|
-
|
EPS
2 |
-
|
-
|
-
|
-
|
1.490
|
1.470
|
1.090
|
-
|
1.150
|
-
|
-
|
-
|
-
|
-
|
-
|
0.7571
|
0.9140
|
0.8594
|
1.096
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.2397
|
0.3596
|
0.3596
|
0.2397
|
0.2509
|
Announcement Date
|
3/11/20
|
7/30/20
|
7/30/21
|
11/11/21
|
3/16/22
|
5/6/22
|
8/3/22
|
8/3/22
|
10/27/22
|
3/27/23
|
5/9/23
|
7/27/23
|
7/27/23
|
11/3/23
|
3/15/24
|
5/10/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
986
|
907
|
776
|
724
|
531
|
335
|
Net Cash position
1 |
173
|
305
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.815
x
|
1.763
x
|
2.07
x
|
1.888
x
|
1.246
x
|
0.7028
x
|
Free Cash Flow
1 |
180
|
232
|
301
|
316
|
198
|
214
|
241
|
274
|
ROE (net income / shareholders' equity)
|
22.6%
|
27.5%
|
26.7%
|
16.6%
|
10.5%
|
11.7%
|
12.8%
|
13.6%
|
ROA (Net income/ Total Assets)
|
-
|
21.5%
|
15.9%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
1,157
|
1,949
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
15.20
|
17.50
|
25.00
|
28.60
|
28.80
|
31.70
|
33.50
|
34.40
|
Cash Flow per Share
2 |
4.250
|
5.560
|
7.010
|
6.740
|
5.590
|
5.730
|
5.950
|
6.740
|
Capex
1 |
52.2
|
73
|
117
|
114
|
113
|
93.8
|
102
|
105
|
Capex / Sales
|
7.39%
|
8.28%
|
9.48%
|
8.35%
|
9.86%
|
7.9%
|
7.97%
|
7.63%
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/16/22
|
3/27/23
|
3/15/24
|
-
|
-
|
-
|
Last Close Price
98.94
EUR Average target price
100.1
EUR Spread / Average Target +1.15% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.16% | 5.72B | | -3.17% | 8.22B | | +31.98% | 5.67B | | -10.03% | 4.11B | | -59.94% | 2.68B | | +11.23% | 2.68B | | -5.14% | 2.37B | | +18.91% | 2.06B | | -7.56% | 1.8B | | +3.07% | 1.6B |
Diagnostic & Testing Substances
|